All Copyright 2007-2020 share Single-X



Advances in single-cell approaches are now enabling us to study differences between tumor cell types and subpopulations at the genome, transcriptome, and epigenome levels. As an unrivaled single cell solution provider, SingleX has abundant experiences in single cell services, and we offer superior quality single-cell omics solutions for oncology to our global customers to advance their oncology programs.

Single Cell Omics Analysis for Tumor

Extensive heterogeneity in cancer cells has a negative impact on treatment efficacy and survival of patients. Traditional molecular methods for biomarker discovery of cancer cells often fail to capture the heterogeneity of cell populations. Recent advances in single cell-based profiling approach allowed the detection of molecular changes in individual cancer cells. Therefore, single cell omics analysis is leading to build a complete landscape of cell types within tumor cells and facilitate the study of molecular heterogeneity in cancer cell populations. With continuous technological improvements, single-cell omics is becoming increasingly prevalent and contribute to the discovery of new and rare cell types, and to the deciphering of disease pathogenesis and outcome. Now, SingleX team provides comprehensive single cell omics solutions for various tumor cell types, including:

Single Cell Omics Solutions for Primary Tumor Cells

The advent of single-cell sequencing has revolutionized the field of cancer genomics, opening the door to a vast number of possibilities. With advances in single cell capture and single-cell analysis techniques, the genome, transcriptome, epigenome and proteome of primary tumor cells can now be discovered to unravel the intratumoral heterogeneity, detect rare cells, profile the tumor microenvironment etc. With the capability of solving the problem of intratumoral heterogeneity, drawing clonal evolution maps, tracking the development of therapeutic resistance, and analyzing rare tumor cell populations, single-cell technology helps to better understand cancer mechanisms, which in turn can provide evidence to guide more effective and personalized treatments.

Intratumor heterogeneity.
Circulating tumor cells.

Single Cell Omics Solutions for Circulating Tumor Cells

Circulating tumor cells (CTCs) are defined as those cells that disseminate from the tumor site and enter the circulation. Numerous studies have highlighted the association between the heterogeneity of CTCs and poor prognosis in patients with various cancer types. Now, the latest single-cell omics analysis technology allows simultaneously interrogating RNA and DNA from a single cell, enabling a parallel analysis of gene expression, methylation status and DNA mutations. Single cell omics analysis of CTCs can reveal the existence and extent of heterogeneity, which is of great clinical significance for understanding and predicting the development of therapeutic resistance in various solid tumors, exploring novel biomarkers, and formulating appropriate treatment strategies.

Single Cell Omics Solutions for Cancer Stem Cells

Cancer stem cells (CSCs) are a subpopulation of cancer cells with self-renewal capacity, that fuel tumor growth and contribute to the heterogeneous nature of tumors. Heterogeneity is the main hallmark of tumor cells such as CSCs, CTCs etc. Each cancer cell clone is characterized by harboring different combinations of mutations or genetic alterations, and subsequently, the processes of tumorigenesis occur differently according to the type of genetic lesions. Single-cell analysis can be used to assess the degree of CSCs heterogeneity at the single cell level and detect small subpopulations that may be missed in bulk populations. Through single cell analysis, it is possible to find CSCs and trace them in the circulation, investigate the clonal evolution and mutational rate of cancer cells, study the tumor invasion, trace the metastatic dissemination and understand the molecular mechanisms of therapy resistance of cancer cells.

At SingleX, we provide our customers with comprehensive single cell omics solutions for primary tumor cells, CTCs, and CSCs. Our single cell omics solutions include but not limited to the followings:

  • Single cell whole genome sequencing (scWGS)
  • Single cell whole exome sequencing (scWES)
  • Single cell targeted sequencing
  • Single cell RNA sequencing (scRNA-seq)
  • Single cell methylation sequencing
  • Single cell proteomic analysis
Cancer stem cells.

In addition to the above services, we can also provide tailor-made single cell omics solutions according to your specific requirements. Please feel free to contact us to learn how SingleX team can be involved in your projects.


  • Verification code
    Click image to refresh the verification code.